NCT06209684

Brief Summary

Previous clinical study carried out on cancer patients at IOR Spine Surgery (approved in October 2014). The carbon device is indicated in patients suffering from vertebral tumors who need stabilization and will then carry out radiotherapy, because carbon has a practically zero level of interference with ionizing radiation. Carbon also allows for better visualization of the implants on MRI/CT and X-ray. There are no studies in the literature analyzing the use of carbon fiber devices in lumbar degenerative pathologies. 118 patients suffering from degenerative spinal pathology requiring 1 or 2 levels of lumbar or lumbosacral fusion will be valutated.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
118

participants targeted

Target at P50-P75 for not_applicable

Timeline
12mo left

Started Apr 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Apr 2022Apr 2027

Study Start

First participant enrolled

April 29, 2022

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

January 4, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 17, 2024

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2026

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 29, 2027

Expected
Last Updated

January 17, 2025

Status Verified

January 1, 2025

Enrollment Period

4 years

First QC Date

January 4, 2024

Last Update Submit

January 16, 2025

Conditions

Keywords

degenerative spine disease

Outcome Measures

Primary Outcomes (1)

  • Fusion rate

    Fusion rate after 12 months as demonstrated by computed tomography scan (CT scan). The CT scan will be evaluated by Brantigan scale.

    through study completion, an average of 1 year

Secondary Outcomes (18)

  • Classification system of surgical complications specific for spine

    at baseline (day 0)

  • Classification system of surgical complications specific for spine

    up to 12 months

  • Visual Analogue Scale

    at baseline (day 0)

  • Visual Analogue Scale

    after 12 months

  • Visual Analogue Scale

    after 3 months

  • +13 more secondary outcomes

Study Arms (2)

Experimental

EXPERIMENTAL

CarboFix implant for spinal surgery

Procedure: Carbofix

Traditional

ACTIVE COMPARATOR

Titanium implant for spinal surgery

Procedure: Titanium

Interventions

TitaniumPROCEDURE

Spinal stabilization using titanium screws and rods

Traditional
CarbofixPROCEDURE

Spinal stabilization using CarboFix screws and rods

Experimental

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients suffering from degenerative spinal pathology or spondylolisthesis who require instrumented stabilization on 1-2 levels;
  • Age greater than or equal to 18 years;
  • Ability to understand and sign the informed consent to the study and to follow the required follow-ups.

You may not qualify if:

  • Metabolic bone disease.
  • History of Paget's disease or other osteodystrophies, whether acquired or congenital, including renal osteodystrophy, hyperthyroidism, hypothyroidism, Ehlers-Danlos syndrome, osteogenesis imperfecta, achondroplasia.
  • Neoplastic disease.
  • History of mental disorder or current psychiatric treatment.
  • Pregnancy.
  • Immunodeficiency diseases.
  • Infectious bone disease (discitis, osteomyelitis)
  • Treatment with drugs that can interfere with bone metabolism
  • Inability to understand and sign the informed consent to the study and to follow the required follow-up visits.
  • Alcohol and/or drug abuse
  • Obesity
  • Metal allergy
  • Participation in other studies on drugs or devices (within 30 days)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istituto Ortopedico Rizzoli

Bologna, 40136, Italy

RECRUITING

Related Publications (3)

  • Boriani S, Tedesco G, Ming L, Ghermandi R, Amichetti M, Fossati P, Krengli M, Mavilla L, Gasbarrini A. Carbon-fiber-reinforced PEEK fixation system in the treatment of spine tumors: a preliminary report. Eur Spine J. 2018 Apr;27(4):874-881. doi: 10.1007/s00586-017-5258-5. Epub 2017 Aug 16.

    PMID: 28815357BACKGROUND
  • Boriani S, Pipola V, Cecchinato R, Ghermandi R, Tedesco G, Fiore MR, Dionisi F, Gasbarrini A. Composite PEEK/carbon fiber rods in the treatment for bone tumors of the cervical spine: a case series. Eur Spine J. 2020 Dec;29(12):3229-3236. doi: 10.1007/s00586-020-06534-0. Epub 2020 Jul 20.

    PMID: 32691220BACKGROUND
  • Vaccaro AR, Garfin SR. Pedicle-Screw Fixation in the Lumbar Spine. J Am Acad Orthop Surg. 1995 Oct;3(5):263-274. doi: 10.5435/00124635-199509000-00002.

MeSH Terms

Conditions

Intervertebral Disc Degeneration

Interventions

Titanium

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Metals, LightElementsInorganic ChemicalsTransition ElementsMetals

Central Study Contacts

Alessandro Gasbarrini, MD

CONTACT

Cristiana Griffoni, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2024

First Posted

January 17, 2024

Study Start

April 29, 2022

Primary Completion

April 29, 2026

Study Completion (Estimated)

April 29, 2027

Last Updated

January 17, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

Locations